Peptide Sciences, one of the most established names in the United States research-peptide supply industry, voluntarily closed on March 6, 2026, leaving researchers who relied on the company for lyophilized research compounds without a source for reorders, standing lab accounts, or lot-matched continuations of ongoing studies. Anyone searching for a Peptide Sciences alternative does not need to start from scratch: the criteria that make any research-peptide supplier trustworthy are the same regardless of brand, namely batch-specific third-party Certificates of Analysis, dual HPLC and mass-spectrometry purity verification, domestic United States shipping, and a transparent, fully specified catalog. Ascension Labs stocks overlapping categories of research compounds under that same standard, and this guide covers how to vet a replacement supplier and where the two catalogs line up.
What Happened to Peptide Sciences
Peptide Sciences announced a voluntary shutdown effective March 6, 2026, ending operations after years as a reference point in the research-peptide space. The company is no longer accepting new orders, and researchers with open protocols, recurring lab purchase orders, or lot-specific reproducibility requirements tied to Peptide Sciences material now need a documented transition plan. This is a logistics and continuity issue rather than a reflection on the underlying research compounds themselves, since the peptides used in preclinical and in-vitro work are defined by chemical identity and purity specification, not by which supplier synthesized a given lot. The practical task for an affected lab is straightforward: identify a supplier that can match or exceed the documentation standard already in place.
Why Sourcing Continuity Matters in Preclinical Research
Reproducibility depends on controlling variables, and the identity and purity of a research compound is one of the most basic variables in any protocol. Switching suppliers mid-study without verifying that new material matches the purity threshold, molecular weight, and sequence identity of the original can introduce an uncontrolled variable into an otherwise carefully designed experiment. Rather than defaulting to the first replacement that appears in a search result, researchers should treat a supplier transition the same way they would treat a new reagent lot, with a documentation check first. That means requesting a current, batch-specific Certificate of Analysis before the first order ships, not after.
What to Look for in a Replacement Supplier
Four criteria separate a durable, trustworthy research-compound supplier from one that may not still be operating a year from now: independent third-party testing, dual analytical verification, domestic shipping logistics, and catalog transparency. Independent testing means every batch is verified by a laboratory with no financial relationship to the seller. Janoshik Analytical is one widely used example in the peptide space, and its reports include a verification key that can be checked directly on the laboratory website. Dual analytical verification means the Certificate of Analysis reports both High-Performance Liquid Chromatography data establishing purity and mass spectrometry data confirming molecular identity, rather than a single summary purity figure with no supporting chromatogram.
Domestic United States shipping matters for practical and continuity reasons alike: it shortens transit time, reducing the window during which lyophilized material sits at ambient temperature, avoids the customs delays that can interrupt a study timeline, and generally reflects that a supplier maintains United States-based inventory rather than drop-shipping from an unverified source. Catalog transparency means product pages list molecular weight, sequence or structure, and lot information rather than vague marketing copy. If a supplier cannot answer a direct question about which laboratory tested a given lot, that is a signal to keep evaluating alternatives rather than placing an order.
Overlapping Research Compound Categories
Researchers coming from Peptide Sciences were typically sourcing across a fairly consistent set of categories: growth hormone secretagogues, tissue-repair research peptides, neuropeptides, and metabolic research compounds. The Ascension Labs catalog overlaps significantly with those categories, including growth hormone axis secretagogues CJC-1295 and Ipamorelin, the full-length GHRH analog Tesamorelin, tissue-repair research peptides BPC-157 and TB-500, the copper-binding tripeptide GHK-Cu, neuropeptides Selank and Semax, plus PT-141, MOTS-c, and NAD+. Every listing includes molecular weight and sequence data alongside a current, batch-specific COA tested by Janoshik Analytical, so researchers can compare specifications directly against what was previously sourced rather than relying on a brand-name match.
Making the Transition Without Disrupting a Protocol
When switching suppliers mid-project, request the COA before placing an order and compare it line by line against documentation from the previous lot: purity percentage, observed versus theoretical molecular weight, and the name of the testing laboratory. For compounds that are frequently studied together in preclinical protocols, such as a GHRH analog paired with a GHSR-1a agonist, it can help to review a direct specification comparison, such as CJC-1295 vs. Ipamorelin or BPC-157 vs. TB-500, before finalizing which variant fits an existing protocol design. Keeping a written record of the supplier transition, including COAs from both the prior and new source, also supports data integrity documentation for lab notebooks or a methods section.
Research Use Notice
All compounds referenced in this article, including those in the Ascension Labs catalog, are sold strictly for laboratory research use only; not for human or veterinary use. Nothing in this guide should be interpreted as a therapeutic claim, dosing recommendation, or endorsement of any application outside of in-vitro or preclinical research conducted by qualified personnel in a controlled laboratory setting.
Frequently Asked Questions
Is Peptide Sciences completely closed, or operating in a reduced capacity? Based on the public announcement of the closure, the shutdown effective March 6, 2026, was a full, voluntary closure, and the company is not processing new orders. Researchers should not assume that a pending order will ship and should independently confirm the status of any outstanding transaction with a payment provider if needed.
What happens to an open research protocol that depended on a specific Peptide Sciences lot? The chemical identity of a compound does not change because a supplier closes, but that specific batch does become unavailable. The practical response is to source a new batch from a documented supplier and record the new COA alongside existing lab notebook entries, so the change in source material stays transparent in methods documentation.
Does the Ascension Labs catalog carry an exact match for every compound Peptide Sciences sold? Catalogs overlap substantially in the categories described above, but researchers should always verify specifications against the current COA for the exact molecule, purity threshold, and format a given protocol requires, rather than assuming a name match guarantees identical specifications.
Does Ascension Labs ship within the United States? Yes, orders ship from domestic United States inventory, which is one of the criteria researchers should require from any Peptide Sciences alternative.
How can a Certificate of Analysis be verified before ordering? Look for a batch-specific report from an independent laboratory such as Janoshik Analytical, confirm it includes both HPLC purity data and mass spectrometry identity confirmation, and check that the laboratory offers independent verification of the report. The Ascension Labs COA page explains what to look for and links current lot documentation for each product.